TARS

Q: What is the price of Tarsus Pharmaceuticals (TARS) today?

The price of Tarsus Pharmaceuticals (TARS) today is US$ 70,38, with a variation of 102.65% compared to the last year. The price of Tarsus Pharmaceuticals (TARS) started the year trading around US$ 55,37 and today it is at US$ 70,38. Follow the real-time price chart, the historical price of Tarsus Pharmaceuticals (TARS), and stock data from Ibovespa and international markets.

Q: When does Tarsus Pharmaceuticals (TARS) pay dividends?

Tarsus Pharmaceuticals (TARS) did not distribute dividends in the last year.

Q: Tarsus Pharmaceuticals (TARS) is it worth it?

Currently, Tarsus Pharmaceuticals (TARS) is priced at US$ 70,38, with a P/E of -30,79%, representing a deviation of -17,84% from its historical average P/E. In the last year, the stock showed a variation of 102.65% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 102,65%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Tarsus Pharmaceuticals (TARS)?

Investing in stocks of Tarsus Pharmaceuticals (TARS) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Tarsus Pharmaceuticals (TARS) yield today?

The yield of Tarsus Pharmaceuticals (TARS) was 24,59% in the last month, 102,65% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Tarsus Pharmaceuticals (TARS) today, the total investment would be US$ 7.038,00, based on the current price of US$ 70,38.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 14.262,51In 5 years: US$ 7.038,00In 10 years: 7.038,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Tarsus Pharmaceuticals Inc.

Price

US$ 70,38

variation (12m)

102,65%

p/l

-30,79

p/vp

8,23

DIVIDEND YIELD

0,00%

price TARS

BVMF

TARS

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of TARS

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

24,59%

3 months

79,63%

1 year

102,65%

2 years

327,06%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

24,59%

3 months

78,97%

1 year

93,76%

2 years

289,78%

5 years

0,00%

10 years

0,00%

Indicators TARS

check out the fundamentals of Tarsus Pharmaceuticals shares

P/E

-30,79

Sector: -1,19 Industry: 0,53

P/SALES RATIO (PSR)

7,82

Sector: 1,95 Industry: 0,83

P/BV

8,23

Sector: 2,22 Industry: 2,35

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-17,96%

Sector: -26,82% Industry: -12,54%

ROE

-26,73%

Sector: -29,98% Industry: -43,78%

ROIC

-400,83%

Sector: -411,56% Industry: -113,08%

NET MARGIN

-25,40%

Sector: -27,32% Industry: -11,31%

GROSS MARGIN

93,54%

Sector: 43,14% Industry: 31,92%

OPERATING MARGIN

-27,16%

Sector: -23,36% Industry: -8,67%

P/EBITDA

-34,79

Sector: 0,02 Industry: 1,61

P/EBIT

-34,01

Sector: -1,26 Industry: 1,41

P/ASSET

5,53

Sector: 1,27 Industry: 0,93

BVPS

7,92

Sector: 3,73 Industry: 5,78

EPS

-2,12

Sector: -0,77 Industry: -0,15

EQUITY / ASSETS

0,67

Sector: 0,45 Industry: 0,28

CAGR REVENUES 5 YEARS

0,00%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

20,50%

Sector: - Industry: -

TARS indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
NVS	17,78	6,13	34,49%	2,92%	US$ 257,90 B	25,52%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
BSX	50,82	6,36	12,51%	0,00%	US$ 144,03 B	14,65%
TMDX	38,43	12,37	32,18%	0,00%	US$ 3,93 B	17,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
IDXX	48,24	34,61	71,76%	0,00%	US$ 50,50 B	25,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%

comparison of TARS with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History TARS

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Tarsus Pharmaceuticals

Tarsus Pharmaceuticals Inc.

Average user rating I10

4.0 (0 people)

Estados Unidos

9 years

Foundation: 2016

2020

Year of debut on the stock exchange - 5 years

20

Employees

The Company Tarsus Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 2,74 Billions, having a net worth of $ 332,61 Milhões.

With a total of 20 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 350,06 Milhões, which generated a loss in the amount of $ -88,91 Milhões.

As for its main indicators, the Company has a P/E ratio of -30,79, a P/BV ratio of 8,23 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker TARS.

Market value

US$ 2,74 Billions

Net worth

US$ 332,61 Milhões

US$ 332.610.000,00

Assets

US$ 494,99 Milhões

US$ 494.990.000,00

Total Number of Shares

42,00 Milhões

42.000.000

Average Daily Trading Volume

US$ 704,72 Thousand

US$ 704.724,26

Sector

Health

Industry

Pharmaceutical Products

TARS

TARS revenue and profits

TARS results

DRAG THE FRAME TO SEE MORE DATA

TARS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

TARS

Tarsus Pharmaceuticals Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of TARS

check out the fundamentals of Tarsus Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Tarsus Pharmaceuticals

Tarsus Pharmaceuticals Inc.

Estados Unidos

9 years

2020

20

PROFIT X PRICE TARS

TARS results

TARS cash flow

evolution of assets - TARS

TARS balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions